Cegedim SA (EPA:ALCGM)
10.50
-0.35 (-3.33%)
Mar 13, 2026, 5:37 PM CET
Cegedim Market Cap
Cegedim has a market cap or net worth of €144.57 million as of March 13, 2026. Its market cap has decreased by -21.32% in one year.
Market Cap
144.57M
Enterprise Value
432.94M
Revenue
658.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
€10.50
Market Cap Chart
Since November 7, 1995, Cegedim's market cap has increased from 113.85M to 144.57M, an increase of 26.98%. That is a compound annual growth rate of 0.79%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Mar 13, 2026 | 144.57M | -22.51% |
| Dec 31, 2025 | 186.56M | 6.71% |
| Dec 31, 2024 | 174.83M | -28.22% |
| Dec 29, 2023 | 243.57M | 22.47% |
| Dec 30, 2022 | 198.89M | -39.93% |
| Dec 31, 2021 | 331.11M | -6.08% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 96.99B |
| Sanofi | 92.07B |
| Sartorius Stedim Biotech | 15.63B |
| Ipsen | 12.82B |
| Bastide Le Confort Médical | 174.35M |
| Guerbet | 153.99M |
| MaaT Pharma | 134.35M |
| Innate Pharma | 126.53M |